Sun Pharma Advanced Research Company Limited — Others, 26-06-2025: Trading Window

Sun Pharma Advanced Research Company has announced a board meeting to approve the financial results for the quarter and half-year ending June 30, 2025. The trading window for the company’s shares will be closed from July 1, 2025, until 48 hours after the financial results are declared, reflecting standard insider trading compliance. This temporary restriction is important for shareholders to note as it limits share transactions during sensitive financial disclosure periods.